News New paediatric use for Allergan's biosimilar-threatened Boto... Allergan’s Botox has another clinical use after the FDA granted approval for children with upper limb spasticity.
News FDA approves Herceptin biosimilar as US patent expires The FDA has approved Amgen and Allergan’s biosimilar of Roche’s Herceptin, just in time for the breast cancer blockbuster’s patent expiry.
News SMC approves medicines for breast cancer, skin cancer, schiz... The Scottish Medicines Consortium (SM
Views & Analysis Collaborating to fight NASH Eric Hughes, Global Development Unit head at Novartis for Immunology, Hepatology & Dermatology, believes that collaboration is going to be key to finally finding a treatment for non
News Discontent at Allergan over CEO's chairman role - report There is discontent among Allergan’s shareholders over CEO Brent Saunders’ dual role as chairman, according to press reports.
News New NHS diabetes strategy could raise GLP-1 drug use New guidelines on NHS management of type 2 diabetes will introduce a more personalised approach that could see expanded access to drug treatments.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
